Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Blood Plasma Derivatives Companies

Blood plasma derivatives companies specialize in the fractionation and processing of blood plasma to produce therapeutic products. These companies provide plasma-derived medications, such as clotting factors, immunoglobulins, and albumin, used in the treatment of various medical conditions, including hemophilia and immune disorders. Blood plasma derivatives companies play a critical role in ensuring a stable supply of life-saving therapies for patients around the world.

Blood Plasma Derivatives Key Companies

Latest Blood Plasma Derivatives Companies Update:

CSL Ltd. Inaugurated their USD 900 million plasma fractionation facility in Australia, significantly expanding their global production capacity and market reach. Partnered with research institutions to explore next-generation plasma-derived therapies and personalized treatment options.

Grifols, S.A. Completed the acquisition of Tiancheng (Germany) Pharmaceutical Holdings AG, a leading plasma protein manufacturer, strengthening their European presence and access to raw materials. Focused on expanding their portfolio of plasma-derived immunoglobulins and albumin products to cater to diverse patient needs.

Takeda Pharmaceutical Company Limited Announced plans to invest USD 300 million in the construction of a new plasma derivatives production facility and warehouse in Belgium, indicating their commitment to long-term market growth. Collaborated with patient advocacy groups to raise awareness about plasma-derived therapies and improve access for individuals with rare diseases.

Octapharma AG Received FDA approval for their Gamifant® (immune globulin intravenous, human [Grifols]) for the treatment of primary immunodeficiency diseases (PIDDs), offering a new option for patients with specific antibody deficiencies. Emphasized their dedication to delivering high-quality and affordable plasma-derived products to patients worldwide.

Baxter International Partnered with a leading plasma fractionation company to expand their access to plasma and ensure continued supply of their critical plasma-derived therapies. Focused on developing innovative delivery systems and dosage forms for plasma-derived medications to improve patient convenience and treatment compliance.

List of Blood Plasma Derivatives companies in the market

Grigols (Spain)

SK Plasma Co. Ltd. (South Korea)

Bain Capital LLC (US)

Biotest AG (Germany)

Baxter International Inc. (US)

Octapharma AG (Switzerland)

CSL Limited (Australia)

Kedrion S.p.A (Italy)

Fusion Healthcare (India)

Blood Plasma Derivatives Market Highlights:

Blood Plasma Derivatives Market Size

Blood Plasma Derivatives Market Trends

Blood Plasma Derivatives Market Analysis

Blood Plasma Derivatives Market Share

Blood Plasma Derivatives Market Highlights:

Blood Plasma Derivatives Market Trends

Blood Plasma Derivatives Market Analysis

Blood Plasma Derivatives Market Share

Blood Plasma Derivatives Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.